A metabolite of Atorvastin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.
Solubility:Methanol (Slightly)
Melting Point:>140°C (dec)
Method for Determining Identity:Proton NMR (CD3OD), 19F NMR (CD3OD) Spectroscopic and Mass Spectrometric Analysis
TLC Conditions:SiO2: Dichloromethane: Methanol: Acetic Acid= 9: 1: 0.1; Visualized with UV and KMnO4; Single spot; Rf=0.50.
Storage and Stability:May be stored at RT for short-term only. Long-term storage is recommended at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Important Note:This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Toxicity and Hazards:All products should be handled by qualified personnel only, trained in laboratory procedures.
